SIM
ANTH

Spark Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Spark Investment Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,050
Closed -$73K – 795
2015
Q1 		$73K Sell
2,050
-10,875
-84% -$322K 0.01% 647
2014
Q4 		$160K Buy
12,925
+8,375
+184% +$122K 0.03% 523
2014
Q3 		$69K Buy
+4,550
New +$95.7K 0.01% 617

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Spark Investment Management's ANTH Position: Q2 2015 in Review

Spark Investment Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2015, closing a stake of 2,050 shares — an estimated $73K sold.

Spark Investment Management first reported a position in ANTH in Q3 2014 and held it in 3 quarters. The position peaked at $160K in Q4 2014. 73 funds tracked by Wall St. Rank hold ANTH as of Q2 2015.

  • Spark Investment Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 2,050 Anthera Pharmaceuticals, Inc. shares in Q2 2015, an estimated $73K.
  • Spark Investment Management first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2014 and held it in 3 quarters.
  • Spark Investment Management's Anthera Pharmaceuticals, Inc. position peaked at $160K in Q4 2014.
  • 73 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.